By clicking the continue button above, I certify I have read the CME/CE information below.
Presented by the American Lung Association
Release Date: March 23, 2018
Expiration Date: March 23, 2019
Despite the availability of guidelines for idiopathic pulmonary fibrosis (IPF) management and new effective treatments, wide variabilities in care still exist. These variations are due, in part, to the difficulties of making a differential diagnosis of IPF and the challenges of developing and implementing cross-functional multidisciplinary team initiatives.
In order to improve health outcomes for patients with IPF, Current Evidence-based Management of Idiopathic Pulmonary Fibrosis: Collaborating To Improve Patient Care will review current evidence-based IPF diagnosis and treatment approaches, strategies for providing effective multidisciplinary care in IPF management, ensuring timely referrals to interstitial lung disease (ILD) centers, and shared decision-making with patients.
Module 1: Making the Diagnosis Early in Disease Course
Module 2: Barriers to Early IPF Diagnosis
Module 3: Multidisciplinary Management and Shared Decision-making in IPF Care
Module 4: Therapeutic Options for Individual IPF Management
Steven Nathan, MD
Professor of Medicine
Virginia Commonwealth University-Inova Fairfax Campus
Medical Director, Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital
Falls Church, VA
Steven D. Nathan, MD is the Director of the Advanced Lung Disease Program and Medical Director of the lung transplant program at Inova Fairfax Hospital in Falls Church, VA. He also is Professor of Medicine at Virginia Commonwealth University, Inova Fairfax Campus. Dr. Nathan received his medical degree at the University of the Witwatersrand Medical School in Johannesburg, South Africa, and he completed his internship in internal medicine and general surgery at the Johannesburg Hospital. Dr. Nathan performed his internal medicine residency at Long Island Jewish Hospital in New York City, and completed his fellowships in pulmonary medicine, critical care, and lung transplantation at Cedars-Sinai Medical Center in Los Angeles, CA. He is board certified in internal medicine, pulmonary diseases, and critical care medicine.
Dr. Nathan has authored more than 400 publications, including original research manuscripts, abstracts, reviews and book chapters. He has also co-edited and authored two books on idiopathic pulmonary fibrosis. Dr. Nathan is a reviewer for multiple journals and is on the editorial board for the journal, Thorax. He has served on multiple committees, including the US Food and Drug Administration advisory boards as well as steering committees for clinical trials in IPF and pulmonary hypertension, where he has also served as chair. Dr. Nathan is a member of several professional medical associations, including the American Thoracic Society, the American College of Chest Physicians, and the International Society for Heart and Lung Transplantation. He has delivered talks and been chairperson of numerous sessions at many national and international conferences.
Leann Silhan, MD
UT Southwestern Medical School
Pulmonary and Critical Care Medicine
Leann Silhan, MD is an Assistant Professor of Internal Medicine at UT Southwestern Medical Center. She received her medical degree at UT Southwestern Medical School, her initial medical and specialty training at University of Maryland Medical Center in Baltimore, MD, and then was on faculty at Johns Hopkins School of Medicine, where she worked as a specialist in both interstitial lung diseases and lung transplantation. During her time at Hopkins, she was honored to have the institution recognized by the Pulmonary Fibrosis Foundation as a Center of Excellence in interstitial lung diseases. She currently specializes in interstitial lung diseases (e.g. idiopathic pulmonary fibrosis, lung disease associated with connective tissue diseases, and hypersensitivity pneumonitis), as well as rare lung diseases. She emphasizes patient-centered individualized care, and enjoys developing long-lasting relationships with patients and their families. A growing, thriving program in interstitial lung disease clinical care and research and a great city and location brought her back to UT Southwestern. Her interests outside medicine include her family, outdoor activities, art and reading.
Angela Scully RN, BSN
Advance Lung Disease and Transplant Program
Inova Fairfax Hospital Transplant Center
Falls Church, VA
Angela Scully, RN, BSN is a Transplant Coordinator at Inova Fairfax Hospital since 2015 where she manages advanced lung disease patients. She graduated in 2005 from Georgia State University with a Bachelor of Science degree in Nursing. Her journey began working in the Intensive Care Unit in Lawrenceville, GA and then transferring to the Perioperative unit to then become their Educator. She then pursued her dream of working with kidney and liver transplant patients at Piedmont Hospital in Atlanta, GA. After moving to Jacksonville, FL and starting a family she started working for the Mayo Clinic in the Perioperative Unit. Wanting to be closer to family, she moved to Virginia to become a Transplant Coordinator.
Tyron V. Lewis, MBA, RRT-NPS, CPFT, RCP
Pulmonary Function Technologist
UT Southwestern Medical Center
Pulmonary Function Laboratories
Tyron V. Lewis, MBA, RRT-NPS, CPFT, RCP has been a Respiratory Therapist/Pulmonary Function Technologist for 27 years at University of Texas Southwestern Medical Center in Dallas, TX. He has held numerous positions, including staff therapist and supervisory posts. He has worked in the Neonatal Intensive Care Unit, Cardiovascular Intensive Care Unit, Medical Intensive Care Unit, and has provided ventilator support in lung and heart transplant surgeries. He has also contracted with private practice physicians to set up pulmonary function equipment including training staff to run the equipment. He also has contracted with medical equipment companies to initiate Bi-PAP and CPAP for their clientele. His last 12 years have been in the Pulmonary Function Laboratory where he sees a large number of interstitial lung disease patients.
He is married with 4 children and lives in Mesquite, TX. He is pursuing a Doctorate in Public Health from Walden University.
At the conclusion of this activity, participants should be able to demonstrate the ability to:
- Integrate evidence regarding the clinical benefits of early diagnosis and optimal diagnostic methods into daily practice of patients with IPF
- Identify barriers to early diagnosis of IPF and implement strategies for mitigation
- Implement multidisciplinary care team approaches in IPF management, including strategies for referral, care coordination, and shared decision-making through provider-patient communication
- Integrate current evidence regarding the safety, efficacy, and utility of pharmacologic and non-pharmacologic therapies for IPF
This activity is intended for community pulmonologists, pulmonary care nurses, registered nurses, pulmonary function technologists, and other healthcare providers diagnosing and managing patients with IPF.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
The Potomac Center for Medical Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information about the accreditation of this program, please email: firstname.lastname@example.org.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, the Potomac Center for Medical Education, and Rockpointe. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Respiratory Care Education
This program has been approved for 1.00 contact hours Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd, Suite 100, Irving TX 75063.
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.
Steering Committee and Program Faculty
The steering committee and faculty reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Tyron V. Lewis, MBA, RRT-NPS, CPFT, RCP: Nothing to disclose
Steven Nathan, MD: Consultant/Independent Contractor: aTyr, Bellerophon Therapeutics, Boehringer Ingelheim, Roche; Grant/Research Support: Boehringer Ingelheim, Roche; Honoraria: Boehringer Ingelheim, Roche; Speaker's Bureau: Boehringer Ingelheim, Roche
Angela Scully, RN, BSN: Nothing to disclose
Leann Silhan, MD: Nothing to disclose
Non-faculty Content Contributors
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Robert D. Saint Laurent, MEd; Chad Williamson, MS, MBA, CMPP; Jeanelle Spencer, PhD; Blair St. Amand; Lindsay Scott, PT, DPT, ATC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CHCP; Judi Smelker-Mitchek, MBA, MSN, RN; Jan Schultz, MSN, RN, CHCP: Nothing to disclose
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an internet browser capable of playing HTML5 videos.
Instructions for Participants and Obtaining CME/CE Credit
There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME/CE activity in its entirety, and then complete the post-test, with a score of 75% or better, and complete the evaluation. The estimated time for completion of this activity is 1 hour. To receive a certificate, participants must demonstrate mastery of the presented material via the module post-test. Participant is allowed to take the post-test multiple times.
Jointly provided by the Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe
This educational program was developed with support from Three Lakes Partners.
Click the "Continue" button below to register.